A review of complications of polyacrylamide hydrogel injection

Chinese Journal of Plastic and Reconstructive Surgery Pub Date : 2023-06-01 DOI:10.1016/j.cjprs.2022.11.003

Chenlu Xiong , Youbai Chen , Yujian Xu , Weiqian Jiang , Xiangye Yin , Dongsheng Chen , Xiaojing Gong , Tian He , Yang An , Yan Han

引用次数: 1

Abstract

Once a popular injectable filler, polyacrylamide hydrogel (PAAG) has been banned in China since 2006 due to its unclear safety and long-term complications. However, it is still being used worldwide because of its huge commercial profit, leading to emerging complications and an urgent need for standardized clinical management. This review aimed to assess the properties, safety, and complications of PAAG and treatment strategies for its removal.

查看原文本刊更多论文

聚丙烯酰胺水凝胶注射液并发症的综述

聚丙烯酰胺水凝胶(PAAG)曾是一种流行的注射填充物，由于其安全性不明确和长期并发症，自2006年以来在中国被禁止使用。然而，由于其巨大的商业利润，仍在世界范围内使用，导致并发症的出现，迫切需要规范的临床管理。本综述旨在评估PAAG的性质、安全性、并发症以及其清除的治疗策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chinese Journal of Plastic and Reconstructive Surgery Surgery, Otorhinolaryngology and Facial Plastic Surgery, Pathology and Medical Technology, Transplantation

CiteScore

0.40

自引率

0.00%

发文量

115

审稿时长

55 days